News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
831,061 Results
Type
Article (85584)
Company Profile (744)
Press Release (744733)
Section
Business (232248)
Career Advice (4103)
Deals (39643)
Drug Delivery (115)
Drug Development (90640)
Employer Resources (194)
FDA (17976)
Job Trends (17271)
News (395560)
Policy (39617)
Tag
Academia (2975)
Alliances (56432)
Alzheimer's disease (1333)
Approvals (17878)
Artificial intelligence (150)
Bankruptcy (394)
Best Places to Work (12515)
Biotechnology (509)
Breast cancer (127)
Cancer (1123)
Career advice (3511)
Cell therapy (257)
Clinical research (71415)
Collaboration (395)
Compensation (195)
COVID-19 (2801)
C-suite (98)
Data (1072)
Diabetes (166)
Diagnostics (6674)
Drug pricing (102)
Earnings (94731)
Employer resources (167)
Events (126664)
Executive appointments (296)
FDA (18507)
Funding (353)
Gene therapy (194)
GLP-1 (691)
Government (5045)
Healthcare (20711)
Infectious disease (2892)
Inflammatory bowel disease (119)
Interviews (807)
IPO (17579)
Job creations (5178)
Job search strategy (2854)
Layoffs (489)
Legal (10042)
Lung cancer (184)
Manufacturing (196)
Medical device (14409)
Medtech (14414)
Mergers & acquisitions (22094)
Metabolic disorders (459)
Neuroscience (1621)
NextGen Class of 2024 (7657)
Non-profit (5063)
Northern California (1453)
Obesity (264)
Opinion (243)
Patents (107)
People (64114)
Pharmaceutical (147)
Phase I (21970)
Phase II (31011)
Phase III (23384)
Pipeline (452)
Postmarket research (3539)
Preclinical (9936)
Radiopharmaceuticals (256)
Rare diseases (231)
Real estate (7372)
Regulatory (25933)
Research institute (2641)
Resumes & cover letters (648)
Southern California (1306)
Startups (4274)
United States (14161)
Vaccines (651)
Weight loss (217)
Date
Today (6)
Last 7 days (980)
Last 30 days (3681)
Last 365 days (38277)
2024 (34729)
2023 (42566)
2022 (53928)
2021 (58726)
2020 (57671)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Arizona (226)
Asia (49308)
Australia (8689)
California (3395)
Canada (1275)
China (251)
Colorado (153)
Connecticut (162)
Europe (112937)
Florida (452)
Georgia (123)
Illinois (413)
Indiana (210)
Kansas (103)
Maryland (620)
Massachusetts (2772)
Michigan (173)
Minnesota (293)
New Jersey (973)
New York (968)
North Carolina (829)
Northern California (1453)
Ohio (143)
Pennsylvania (842)
South America (1647)
Southern California (1306)
Texas (482)
Washington State (392)
There are 831,061 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
International Cancer Organizations Present Collaborative Work During Oncology Event in China
November 18, 2024
·
3 min read
Press Releases
Idorsia’s once-daily TRYVIO™ (aprocitentan) is now available in the U.S., advancing treatment options for millions of patients with difficult-to-control hypertension
November 18, 2024
·
13 min read
Press Releases
Theralase(R) Closes Non-Brokered Private Placement
November 18, 2024
·
5 min read
Press Releases
Bio-Path Holdings Reports Third Quarter 2024 Financial Results
November 18, 2024
·
8 min read
Press Releases
Opthea Appoints Kathy Connell to Board of Directors
November 18, 2024
·
6 min read
Editorial
AbbVie’s Setback Gives BMS Commanding Lead in Schizophrenia Space
With the failure of AbbVie’s emraclidine in two mid-stage trials, Bristol Myers Squibb’s Cobenfy is ‘sole muscarinic winner.’
November 18, 2024
·
5 min read
·
Heather McKenzie
Press Releases
PharmaDrug Announces Issuance of Debenture Units
November 15, 2024
·
5 min read
Press Releases
PreveCeutical Announces Closing of BioGene Therapeutics Transaction
November 15, 2024
·
4 min read
Press Releases
Eyenovia Provides Update on Phase 3 CHAPERONE Study
November 15, 2024
·
5 min read
Press Releases
Medicenna Reports Second Quarter Fiscal 2025 Financial Results and Corporate Update
November 15, 2024
·
11 min read
1 of 83,107
Next
